Skip to content
Catalyst

astaxanthinFinding

Astaxanthin inhibits KEAP1

lowersInsufficient evidenceFinding

01 · The sentence it was drawn from

“Additionally, ASX could inhibit the expression of Keap1, promote the transport of Nrf2 from cytoplasm to nucleus and facilitate the expressions of HO-1, NQO1, γ-glutamylcysteine synthetase, (γ-GCS) and GPx.”
Quoted verbatim from Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy.
This finding among the 2 findings on its endpoint

astaxanthin

KEAP1

inhibits

Who
streptozotocin-induced diabetic retinopathy rats, retinal tissue
Dose studied
20 mg/kg for 45 days

Insufficient evidencePMID 37343496 · 2023

02 · The study

Study
animal · not in humans
Duration
6 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3J8E59G36AN3DZ1EFT0AW7M